Skip to content

Placebo suspension

DRUG13 trials

Sponsors

University of Ulm, Yale University, GlaxoSmithKline, Pfizer, Johannes Gutenberg University Mainz

Conditions

ADHDAcute Myocardial InfarctionCoronary Artery DiseaseDiabetes Mellitus, Type 1Drug Sensitive TuberculosisDrug-resistant TuberculosisFunctional Abdominal PainFunctional Dyspepsia

Phase 1

Study to Assess Cardiac Conduction of GSK1349572
CompletedNCT00996021
GlaxoSmithKlineHealthy Subjects
Start: 2009-09-30End: 2009-12-31Updated: 2010-01-25
Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin
CompletedNCT01127906
PfizerHealthy
Start: 2010-06-30End: 2010-09-30Updated: 2010-09-23
Relationship Between Gastric Emptying and Glycemic Variability in Type 1 Diabetes Mellitus
CompletedNCT02755064
Adil BharuchaDiabetes Mellitus, Type 1
Start: 2010-06-30End: 2013-11-30Updated: 2016-04-28
A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of TBI-223 in Healthy Adults
CompletedNCT03758612
Global Alliance for TB Drug DevelopmentTuberculosis, Tuberculosis, Pulmonary
Start: 2019-01-16End: 2020-03-15Updated: 2024-12-09
Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults
CompletedNCT04493671
Global Alliance for TB Drug DevelopmentDrug-resistant Tuberculosis, Drug Sensitive Tuberculosis, Multi Drug Resistant Tuberculosis +4
Start: 2020-06-08End: 2022-11-15Updated: 2025-06-04
First-in-Human, Multiple Part Clinical Study of JNT-517 in Healthy Participants and in Participants With Phenylketonuria
Active, not recruitingNCT05781399
Otsuka Pharmaceutical Development & Commercialization, Inc.Phenylketonuria
Start: 2022-10-31End: 2025-12-15Target: 135Updated: 2025-07-31
A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis
WithdrawnNCT06260267
Ferring PharmaceuticalsUlcerative Colitis
Start: 2024-03-12End: 2026-01-15Updated: 2024-10-18

Phase 2

Phase 3

Unknown Phase

Related Papers